| Display title | Medicine:High-dose chemotherapy and bone marrow transplant |
| Default sort key | HDC BMT |
| Page length (in bytes) | 48,175 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 310326 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>DanMescoff |
| Date of page creation | 23:44, 4 February 2024 |
| Latest editor | imported>DanMescoff |
| Date of latest edit | 23:44, 4 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | High-dose chemotherapy and bone marrow transplant (HDC/BMT), also high-dose chemotherapy with autologous bone marrow transplant (HDC/ABMT or just ABMT), was an ineffective treatment regimen for metastatic breast cancer, and later high-risk breast cancer, that was considered promising during the 1980s... |
